Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © 2024 The Author(s). |
| Dates: |
|
| Institution: | The University of York |
| Academic Units: | The University of York > Faculty of Social Sciences (York) > Economics and Related Studies (York) The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York) |
| Depositing User: | Pure (York) |
| Date Deposited: | 18 Dec 2024 09:00 |
| Last Modified: | 04 Apr 2025 23:14 |
| Published Version: | https://doi.org/10.1016/S0140-6736(24)02352-3 |
| Status: | Published online |
| Refereed: | Yes |
| Identification Number: | 10.1016/S0140-6736(24)02352-3 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:220955 |
Download
Filename: 1-s2.0-S0140673624023523-main.pdf
Description: Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis
Licence: CC-BY 2.5
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)